Clinical Project Manager at Relay Therapeutics

Cambridge, Massachusetts, United States

Relay Therapeutics Logo
Not SpecifiedCompensation
Mid-level (3 to 4 years), Senior (5 to 8 years)Experience Level
Full TimeJob Type
UnknownVisa
Biotechnology, PharmaceuticalsIndustries

Requirements

  • 5+ years of experience in clinical study management (sponsor experience strongly preferred)
  • Recognized as a clinical operations expert with a track record of success in study execution, accelerating timelines, maintaining data integrity, and satisfying health authority requirements
  • Experience executing clinical studies across various phases (desirable); expertise in oncology drug development preferred
  • Strong and current knowledge of global regulatory and compliance requirements, including US CFR, EU CTD, and ICH GCP applicable to clinical trials
  • Experience in CRO, vendor, and laboratory oversight
  • Motivated self-starter capable of flourishing in a fast-paced small company environment
  • Creative problem-solver with excellent communication and public speaking skills

Responsibilities

  • Oversee day-to-day operations of study execution, focusing on site oversight from startup to closeout, patient enrollment, monitoring, compliance, and data flow/metrics from sites, CROs, and vendors
  • Collaborate with cross-functional team to deliver studies on time, within budget, and in accordance with protocol and ICH GCP guidelines
  • Develop and maintain strong relationships with investigators, site staff, and vendors globally, explaining complex scientific topics
  • Manage reports communicating study progress and key metrics to Senior Management and program teams
  • Contribute to or author key study documents (e.g., protocols, informed consent forms, case report forms, governance charters, study plans, clinical study reports)
  • Manage vendors as primary point of contact, identify/resolve risks, ensure contracts meet requirements with KPIs, and partner on budgeting/cost accrual
  • Ensure quality data by reviewing monitoring reports, protocol deviations, data listings, and performing/overseeing site monitoring visits
  • Develop action plans for protocol compliance, safety, data, and administrative issues with sites and CROs
  • Coordinate with CROs on site selection, IRB/EC submissions, site initiation, and close-out planning
  • Provide oversight and maintain clinical trial master files (TMF) for compliance with regulatory, ICH GCP, and SOP standards
  • Partner with CRO to lead, plan, and execute Investigator meetings and study meetings
  • Participate in preparation of regulatory filings (e.g., IND, NDA, orphan drug applications)
  • Ensure inspection readiness by collaborating with CROs and supporting sites for audits/inspections
  • Assist with onboarding and mentoring new or junior clinical operations associates

Skills

Clinical Trial Management
CRO Management
Vendor Management
ICH GCP
Site Management
Protocol Development
Informed Consent Forms
Case Report Forms
Data Monitoring
Patient Enrollment
Budget Management
Regulatory Compliance

Relay Therapeutics

Biotech company focused on drug discovery

About Relay Therapeutics

Relay Therapeutics focuses on drug discovery by studying protein motion to develop new treatments for complex diseases. Their main tool, the Dynamo™ platform, uses both experimental and computational methods to identify potential drug candidates, especially for conditions that are hard to treat with current therapies. This platform allows them to target proteins that have previously been difficult to address, particularly in areas like precision oncology and genetic diseases. Unlike many competitors, Relay Therapeutics emphasizes the importance of protein dynamics in their research, which sets them apart in the biotech field. Their goal is to create effective medicines that can significantly improve patients' lives, and they are actively conducting clinical trials to ensure the safety and effectiveness of their drug candidates.

Cambridge, MassachusettsHeadquarters
2016Year Founded
$535MTotal Funding
IPOCompany Stage
Biotechnology, HealthcareIndustries
201-500Employees

Benefits

Medical, dental, vision
Life, disability, & FSA
401k
Commuter benefits
Parental leave
Home office stipend
Tuition reimbursement
PTO

Risks

Increased competition from VantAI threatens Relay's market position.
Layoffs may impact Relay's operational efficiency and research progress.
Reliance on public offerings suggests potential financial instability for Relay.

Differentiation

Relay's Dynamo platform targets previously undruggable proteins, expanding treatment possibilities.
Focus on protein motion places Relay at the forefront of innovative drug discovery.
Relay's precision oncology approach tailors treatments to individual genetic profiles.

Upsides

AI-driven drug discovery complements Relay's computational techniques, enhancing drug development.
Quantum computing integration could boost Dynamo's capabilities in drug discovery.
Rising personalized medicine trend aligns with Relay's precision medicine focus.

Land your dream remote job 3x faster with AI